Bristol-Myers Squibb Company

Bristol-Myers Squibb Beats on EPS, Stock Up 2.89%

Bristol-Myers Squibb's earnings report showed a positive surprise in EPS, which likely contributed to the stock's 2.89% increase. However, without revenue figures or management commentary, it's difficult to assess the overall performance and future outlook. Investors may be encouraged by the EPS beat but will need more information to gauge long-term prospects.